Roche has signed up for access to Vividion Therapeutics' proteomics screening platform and proprietary small molecule library to target E3 ligases and a range of onc...

Novartis' gene therapy arm AveXis has announced European approval for Zolgensma (onasemnogene abeparvovec), the only gene therapy for spinal muscular atrophy (SMA). ...

Scientists at the Institute of Cancer Research (ICR) are warning that delays to cancer surgery and other treatment caused by the COVID-19 pandemic could be linked to...

As of this morning – Wednesday May 13 – the current recorded case count for COVID-19 (coronavirus) in the UK has hit 226,463 with 32,692 deaths. Genomics England i...

As of this morning – Wednesday May 13 – the current recorded case count for COVID-19 (coronavirus) in the UK has hit 226,463 with 32,692 deaths. A trial of medicin...

The National Institute for Health and Care Excellence (NICE) has published guidance recommending the use of Pfizer's Lorviqua (lorlatinib) for a certain form of lung...

The UK's Medicines & Healthcare products Regulatory Agency (MHRA) has approved Oxford Biomedica for two new manufacturing sites in Oxford. Following an inspect...

In the US, clinical stage biotech Moderna has bagged fast track designation for its mRNA vaccine candidate (mRNA-1273) against novel coronavirus (SARS-CoV-2). Fast...

Call it Libtayo’s month. After last week posting key data that could help it enter the lucrative non-small cell lung cancer market, the Sanofi and Regeneron immuno-o...

As COVID-19 ravages across the globe, Regeneron has responded with its own two-pronged approach against the disease. After early results in China showed inhibiting...